National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 615899

History of Changes from the VAERS Wayback Machine

First Appeared on 3/14/2016

VAERS ID: 615899
VAERS Form:
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / - LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 9/14/2017

VAERS ID: 615899 Before After
VAERS Form:(blank) 1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / - UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 2/14/2018

VAERS ID: 615899 Before After
VAERS Form:1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 6/14/2018

VAERS ID: 615899 Before After
VAERS Form:1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 8/14/2018

VAERS ID: 615899 Before After
VAERS Form:1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 9/14/2018

VAERS ID: 615899 Before After
VAERS Form:1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 10/14/2018

VAERS ID: 615899 Before After
VAERS Form:1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 12/24/2020

VAERS ID: 615899 Before After
VAERS Form:1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 12/30/2020

VAERS ID: 615899 Before After
VAERS Form:1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 5/7/2021

VAERS ID: 615899 Before After
VAERS Form:1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.


Changed on 5/14/2021

VAERS ID: 615899 Before After
VAERS Form:1
Age:18.0
Sex:Female
Location:Connecticut
Vaccinated:2015-08-31
Onset:2015-09-01
Submitted:2015-12-17
Entered:2015-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Asthma

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK177972

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of asthmatic attack in a 19-year-old female patient who received BEXSERO (batch number 148901A, expiry date 30th September 2016). On 31st August 2015, the patient received BEXSERO .5 ml. In September 2015, several days after receiving BEXSERO, the patient experienced asthmatic attack. On an unknown date, the outcome of the asthmatic attack was recovered/resolved. It was unknown if the reporter considered the asthmatic attack to be related to BEXSERO. Additional details were received as follows: In September 2015, few days after receiving BEXSERO vaccine, the patient experienced asthma attack. The date when patient experienced asthma attack was not available.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=615899&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166